MBP metabolic pharmaceuticals limited

csiro: polynovo cost benefit analysis, page-8

  1. 989 Posts.
    Hi stormer,

    Just realized we are a few of the same jrv zyl and mbp.
    I only have small holdings in jrv and mbp. Seems incredible that this dog may come good. The fact that I won't go in heavily with mbp will ensure its success lol.
    aslo holding imi and sen. my porfolio sucks.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.